Bioceres Crop Solutions (NASDAQ:BIOX) Given New $12.00 Price Target at Oppenheimer

Bioceres Crop Solutions (NASDAQ:BIOX) had its target price decreased by investment analysts at Oppenheimer from $13.00 to $12.00 in a research report issued on Tuesday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Oppenheimer’s price target indicates a potential upside of 71.43% from the stock’s previous close.

Separately, Canaccord Genuity Group cut their target price on Bioceres Crop Solutions from $10.00 to $9.50 and set a “buy” rating on the stock in a research note on Wednesday, November 13th. Four equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Buy” and a consensus target price of $11.88.

Bioceres Crop Solutions Stock Performance

Shares of NASDAQ:BIOX opened at $7.00 on Tuesday. The stock has a market capitalization of $438.97 million, a P/E ratio of 350.18 and a beta of 0.56. The company has a current ratio of 1.27, a quick ratio of 0.87 and a debt-to-equity ratio of 0.37. Bioceres Crop Solutions has a 1-year low of $5.71 and a 1-year high of $14.05. The business has a 50-day moving average price of $6.66 and a two-hundred day moving average price of $8.04.

Bioceres Crop Solutions (NASDAQ:BIOX) last announced its quarterly earnings data on Monday, November 11th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.11). The business had revenue of $92.60 million during the quarter, compared to the consensus estimate of $117.15 million. Bioceres Crop Solutions had a net margin of 0.53% and a return on equity of 0.68%. During the same period in the previous year, the business posted ($0.07) earnings per share. Equities analysts predict that Bioceres Crop Solutions will post 0.12 earnings per share for the current year.

Institutional Trading of Bioceres Crop Solutions

Several hedge funds have recently added to or reduced their stakes in the business. Dimensional Fund Advisors LP increased its holdings in shares of Bioceres Crop Solutions by 9.5% in the second quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company’s stock worth $688,000 after acquiring an additional 5,341 shares in the last quarter. Fourth Sail Capital LP grew its position in shares of Bioceres Crop Solutions by 61.6% in the 3rd quarter. Fourth Sail Capital LP now owns 3,171,102 shares of the company’s stock valued at $24,957,000 after purchasing an additional 1,209,277 shares during the period. Stifel Financial Corp increased its stake in Bioceres Crop Solutions by 33.4% during the 3rd quarter. Stifel Financial Corp now owns 40,790 shares of the company’s stock worth $321,000 after purchasing an additional 10,224 shares in the last quarter. JPMorgan Chase & Co. raised its holdings in Bioceres Crop Solutions by 49.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company’s stock worth $708,000 after buying an additional 29,693 shares during the period. Finally, Ping Capital Management Inc. lifted its stake in Bioceres Crop Solutions by 7.3% in the fourth quarter. Ping Capital Management Inc. now owns 44,000 shares of the company’s stock valued at $268,000 after buying an additional 3,000 shares in the last quarter. Institutional investors and hedge funds own 17.68% of the company’s stock.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.